기도 관리 기기 : 세계 시장 인사이트, 경쟁 환경 및 시장 예측(2030년)

Airway Management Devices Market By Type (Infraglottic Devices [Endotracheal Tubes, Tracheostomy Tubes, Others], Supraglottic Devices [Oropharyngeal Devices, Nasopharyngeal Devices, Laryngeal Airway Devices, Others], Resuscitators, Laryngoscopes, and Others), By Application (Emergency Medicine, Anesthesia, and Others), By End-User (Hospitals, Ambulatory Surgical Care Centers, and Others), By Geography, is expected to grow at a steady CAGR forecast till 2030 owing to the favorable reimbursement policies and increasing prevalence of chronic respiratory diseases

Global Airway Management Devices Market was valued at USD 1.60 billion in 2023, growing at a CAGR of 6.21% during the forecast period from 2024 to 2030, to reach USD 2.29 billion by 2030. The demand for Airway Management Devices is primarily attributed to the rising prevalence of chronic respiratory diseases such as asthma and COPD, the outbreak of the COVID-19 pandemic, increasing admissions across emergency & intensive care units, increasing air pollution, rise in geriatric population, growing investments in healthcare infrastructure, favorable reimbursement coverage across developed countries.

Airway Management Devices Market Dynamics:

Airway Management Devices Market has significantly increased owing to the growing burden of respiratory diseases throughout the world, and these devices play an important role in clearing the airway passage for pulmonary disorders such as COPD, asthma, bronchitis, emphysema, and acute pneumonia. As per World Health Organization (WHO) 2019, asthma affected an estimated 262 million people and caused 461,000 deaths globally. Additionally, Chronic obstructive pulmonary disease (COPD) is the third-most-leading cause of death, causing 3.23 million deaths worldwide. Moreover, environmental exposure to tobacco smoke, indoor air pollution, and occupational dust, fumes, and chemicals are important risk factors for COPD. As per WHO 2022 statistics, 99% of the world population was living in places where the WHO air quality guidelines levels were not met, in 2019.

An increase in the aging population and changes in social behavior contributes to the constant increase in these common and expensive long-term health problems. The high prevalence of respiratory diseases coupled with an increase in anesthesia usage, owing to the rise in the number of surgeries, is expected to propel the demand for advanced airway management devices, thus, exerting a positive impact on the overall Global Airway Management Devices Market growth. In addition, key players are entering into strategic collaborations to advance at a great pace, stimulated by innovations in technologies.

Also, the outbreak of the COVID-19 pandemic had a profound impact on the global Airway Management Devices Market. A large number of patients required intubation which comes with chances of fatal airway complications. To provide easy breathing support to patients, innovations to develop unique devices took place, which increased the demand for Airway Management Devices, further favoring the growth of the Airway Management Devices market.

For instance, Era's Lucknow Medical College and Hospital (India) developed and applied for the patent of a novel video laryngoscope. The traditional laryngoscopes being bulky, expensive, and without a camera, replacing with the innovative device which is cheaper, provides seamless intubation with constant oxygen supply and camera that can be accessed on a phone, tablet, or monitor.

Certain factors such as lack of skilled professionals, harmful effects associated with the devices, and also the high cost of the devices pose a minor hurdle for the growth of the Airway Management Devices market.

Airway Management Devices Market Segment Analysis:

Airway Management Devices Market by Type (Infraglottic [Endotracheal Tubes, Tracheostomy Tubes, Others], Supraglottic [Oropharyngeal Devices, Nasopharyngeal Devices, Laryngeal Airway Devices, Others], Resuscitators, Laryngoscopes, and Others), Airway Management Devices Market by Application (Emergency Medicine, Anaesthesia, and Others), Airway Management Devices Market by End User (Hospitals, Ambulatory Surgical Care Centers, and Others), and Airway Management Devices Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Global Airway Management Devices market by type segment, the Supraglottic devices market segment will grow at a significant CAGR during the forecast period from 2024-2030.

The rapid growth of this product segment can be attributed to the fact that these devices provide convenient tracheal placement, bypass the upper airway, provides low airway resistance, allows both positive pressure and spontaneous ventilation, and many others, which promotes their utility in a wide range of applications, thereby, creating a preference among patients and physicians toward these devices. Additionally, the growing prevalence of chronic respiratory diseases, cardiovascular diseases, and respiratory tract infections are increasing the incidence of acute respiratory failure, thereby driving the demand for procedures and supraglottic devices globally.

Moreover, favorable reimbursement policies by the government bodies are expected to enhance the market potential of this equipment. Hence, all the above-mentioned factors are expected to drive the segment growth of the Airway Management Devices market.

North America is expected to dominate the overall Airway Management Devices Market:

Among all the other regions, North America is expected to dominate the overall Airway Management Devices market during the forecast period. This domination can be primarily attributed to the rising prevalence of chronic respiratory conditions, rising levels of air pollution, increase in expenditure on these devices, and technological advancements in this region.

Further, the United States represents the largest market worldwide supported by the rising levels of air pollution, developed healthcare system and infrastructure, favorable reimbursement policies. For instance, in 2020, about 68 million tons of pollution were emitted into the atmosphere in the United States as per the United States Environmental Protection Agency, 2022 report. Thus, these critical condition is likely to increase the risk of developing COPD, Asthma and other conditions, thereby augmenting the market for Airway Management Devices market. In addition, rising surgical procedures is also one of the major factors driving the Airway Management Devices market growth.

Furthermore, a significant number of prominent vendors, commercialization activities such as merger acquisition, collaboration, and others among major key players, also new product launches are the factors that are expected to drive the market. For instance, in September 2019, Olympus launched two video rhino-laryngoscopes specifically designed for laryngological examinations. Hence, contributing to the Airway Management Devices market growth.

Asia-Pacific region has the future potential growth for the Global Airway Management Devices. This is owing to the rising burden of the geriatric population who are susceptible to developing chronic respiratory disorders. Rapid urbanization, increase in disposable income, penetration by emerging local players in the market, rising awareness related to advanced healthcare technologies is likely to surge the Airway Management Devices market during the forecasted period.

Airway Management Devices Market Key Players:

Some of the key market players operating in the Airway Management Devices market include Smiths Medical PLC, Narang Medical Limited, Intersurgical Ltd., Teleflex Incorporated, Stryker Corporation, Medtronic PLC, Dilon Technologies® Inc., Ambu A/S, Medline Industries, LP, ConvaTec Inc., KARL STORZ Endoscopy-America, Inc., Flexicare (Group) Limited, SunMed, Vyaire Medical, Inc., VBM Medizintechnik GmbH, Verathon, Inc., SourceMark(TM), Mercury Medical, TRACOE medical GmbH, Olympus Corporation, and others.

Recent Developmental Activities in the Airway Management Devices Market:

In August 2020, Verathon launched the GlideScope Video Baton QC Large, a video laryngoscope used with GlideScope Core airway management devices.

In January 2020, Smiths Medical added a PVC-based tracheostomy tube portfolio to its Portex Tracheostomy Tubes and Kits.

In January 2020, VVerathon launched GlideScope Core 15 airway visualization system to deliver enhanced visibility using a 15-inch, high definition monitor with touchscreen features.

Key Takeaways from the Airway Management Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyse suitable indicators, our experts are closely watching the Airway Management Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Airway Management Devices Market.

Various opportunities are available for the other competitor in the Airway Management Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Airway Management Devices market growth in the coming future?

Target Audience who can be benefited from this Airway Management Devices Market Report Study

Airway Management Devices providers

Research organizations and consulting companies

Airway Management Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Airway Management Devices

Various End-users want to know more about the Airway Management Devices Market and the latest technological developments in the Airway Management Devices market.

Frequently asked questions for airway management devices market:

1. What are Airway Management Devices?

Airway Management Devices are devices used to prevent or relieve any type of airway blockage, which employs a set of medical techniques and devices used by medical experts.

2. What is the market for Global Airway Management Devices?

Global Airway Management Devices Market was valued at USD 1.60 billion in 2023, growing at a CAGR of 6.21% during the forecast period from 2024 to 2030, to reach USD 2.29 billion by 2030.

3. What are the drivers for Global Airway Management Devices?

The major drivers driving the demand for Airway Management Devices are the outbreak of the COVID-19 pandemic, increasing admissions across emergency & intensive care units, rising prevalence of chronic respiratory diseases such as asthma and COPD, increasing air pollution, rise in geriatric population, growing investments in healthcare infrastructure, favorable reimbursement coverage across developed countries.

4. What are the key players operating in Global Airway Management Devices?

Some of the key market players operating in the Airway Management Devices market include Smiths Medical PLC, Narang Medical Limited, Intersurgical Ltd., Teleflex Incorporated, Stryker Corporation, Medtronic PLC, Dilon Technologies® Inc., Ambu A/S, Medline Industries, LP, ConvaTec Inc., KARL STORZ Endoscopy-America, Inc., Flexicare (Group) Limited, SunMed, Vyaire Medical, Inc., VBM Medizintechnik GmbH, Verathon, Inc., SourceMark(TM), Mercury Medical, TRACOE medical GmbH, Olympus Corporation, and others.

5. Which regions have the highest share in the Airway Management Devices market?

North America is expected to dominate the overall Airway Management Devices market during the forecast period, 2024 to 2030. This domination can be primarily attributed to the rising prevalence of chronic respiratory conditions, rising levels of air pollution, increase in expenditure on these devices, and technological advancements in this region.

Table of Contents

1. Airway Management Devices Market Report Introduction

2. Airway Management Devices Market Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
  • 3.2.1. Germany
  • 3.2.2. France
  • 3.2.3. Italy
  • 3.2.4. Spain
  • 3.2.5. The U.K.
• 3.3. Japan

4. Airway Management Devices Market Key factors analysis

• 4.1. Airway Management Devices Market Drivers
  • 4.1.1. The rise outbreak of epidemic and pandemic such as COVID-19
  • 4.1.2. Increasing admissions across emergency & intensive care units
  • 4.1.3. The rising prevalence of Chronic Respiratory Diseases
  • 4.1.4. Increasing air pollution
• 4.2. Airway Management Devices Market Restraints and Challenges
  • 4.2.1. High cost of the devices
  • 4.2.2. Harmful effects associated with the devices
• 4.3. Airway Management Devices Market Opportunities
  • 4.3.1. Growing preference towards advanced devices
  • 4.3.2. Growth opportunities in emerging countries

5. Airway Management Devices Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Airway Management Devices Market

7. Airway Management Devices Market layout

• 7.1. By Type
  • 7.1.1. Infraglottic Devices
    • 7.1.1.1. Endotracheal Tubes
    • 7.1.1.2. Tracheostomy Tubes
    • 7.1.1.3. Others
  • 7.1.2. Supraglottic Devices
    • 7.1.2.1. Oropharyngeal Devices
    • 7.1.2.2. Nasopharyngeal Devices
    • 7.1.2.3. Laryngeal Airway Devices
    • 7.1.2.4. Others
  • 7.1.3. Resuscitators
  • 7.1.4. Laryngoscopes
  • 7.1.5. Others
• 7.2. By Application
  • 7.2.1. Emergency Medicine
  • 7.2.2. Anaesthesia
  • 7.2.3. Others
• 7.3. By End User
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Surgical Care Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America Airway Management Devices Market, by Type
    • 7.4.1.2. North America Airway Management Devices Market, by Application
    • 7.4.1.3. North America Airway Management Devices Market, by End User
    • 7.4.1.4. North America Airway Management Devices Market, by Country
    • 7.4.1.4.1. United States
    • 7.4.1.4.2. Canada
    • 7.4.1.4.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe Airway Management Devices Market, by Type
    • 7.4.2.2. Europe Airway Management Devices Market, by Application
    • 7.4.2.3. Europe Airway Management Devices Market, by End User
    • 7.4.2.4. Europe Airway Management Devices Market, by Country
    • 7.4.2.4.1. France
    • 7.4.2.4.2. Germany
    • 7.4.2.4.3. United Kingdom
    • 7.4.2.4.4. Italy
    • 7.4.2.4.5. Spain
    • 7.4.2.4.6. Russia
    • 7.4.2.4.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific Airway Management Devices Market, by Type
    • 7.4.3.2. Asia-Pacific Airway Management Devices Market, by Application
    • 7.4.3.3. Asia-Pacific Airway Management Devices Market, by End User
    • 7.4.3.4. Asia-Pacific Airway Management Devices Market, by Country
    • 7.4.3.4.1. China
    • 7.4.3.4.2. Japan
    • 7.4.3.4.3. India
    • 7.4.3.4.4. Australia
    • 7.4.3.4.5. South Korea
    • 7.4.3.4.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW Airway Management Devices Market, by Type
    • 7.4.4.2. RoW Airway Management Devices Market, by Application
    • 7.4.4.3. RoW Airway Management Devices Market, by End User
    • 7.4.4.4. RoW Airway Management Devices Market, by Region
    • 7.4.4.4.1. Middle East
    • 7.4.4.4.2. Africa
    • 7.4.4.4.3. South America

8. Airway Management Devices Global Company Share Analysis - Key 3-5 Companies

9. Airway Management Devices Company and Product Profiles

• 9.1. Smiths Medical PLC
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Narang Medical Limited
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Intersurgical Ltd.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Teleflex Incorporated
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Stryker Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Medtronic PLC
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Dilon Technologies® Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Ambu A/S
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Medline Industries, LP
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. ConvaTec Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. KARL STORZ Endoscopy-America, Inc.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Flexicare (Group) Limited
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. SunMed
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Vyaire Medical, Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. VBM Medizintechnik GmbH
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Verathon, Inc.
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. SourceMark(TM)
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Mercury Medical
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. TRACOE medical GmbH
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Olympus Corporation
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. Project Approach

• 10.1. Secondary Sources
• 10.2. Primary Sources
• 10.3. Data Triangulation
• 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight